Uptravi
Brand Name: Uptravi
Generic Name: Selexipag
Active
Registration Number
DR-XY47396
Dosage Form
Film-Coated Tablet
Issuance Date
May 14, 2025
Expiry Date
September 20, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1.6 mg
PackagingAlu/Alu Blister Pack with embedded desiccant x 10's
(Box of 60's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antithrombotic Agent
A
Application
Initial (from Monitored Release)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
SelexipagActive
Monograph: Selexipag